All-trans retinoic acid influences viability, migration and adhesion of U251 glioblastoma cells

Autor: Marjanović-Vićentić Jelena, Schwirtlich Marija, Kovačević-Grujičić Nataša, Stevanović Milena, Drakulić Danijela
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Zdroj: Archives of Biological Sciences, Vol 69, Iss 4, Pp 699-706 (2017)
Druh dokumentu: article
ISSN: 0354-4664
1821-4339
DOI: 10.2298/ABS170327016M
Popis: Glioblastoma (GBM) is one of the most aggressive and deadly forms of cancer. Literature data reveals that all-trans retinoic acid (ATRA) has anticancer effects on different types of tumor cells. However, data about the effects of ATRA on glioblastoma cells are contradictory. In this study, we examined whether ATRA treatment affects features of human glioblastoma U251 cells. To that end, the cells were treated with different concentrations of ATRA. Results obtained by MTT and the crystal violet assays imply that ATRA affected the viability of U251 glioblastoma cells in a dose- and time-dependent manner. Fluorescence staining of microtubule cytoskeleton protein α-tubulin revealed that ATRA induced changes in cell morphology. Using semi-quantitative RT-PCR we found that the expression of SOX3 and GFAP genes, as markers of neural differentiation, was not changed upon ATRA treatment. Thus, the observed changes in cell morphology after ATRA treatment are not associated with neural differentiation of U251 glioblastoma cells. The scratch-wound healing assay revealed that ATRA changed the mode of U251 cell migration from collective to single cell motility. The cell-matrix adhesion assay demonstrated that the pharmacologically relevant concentration of ATRA lowered the cell-matrix adhesion capability of U251 cells. In conclusion, our results imply that further studies are needed before ATRA could be considered for the treatment of glioblastoma. [Project of the Serbian Ministry of Education, Science and Technological Development, Grant no. 173051]
Databáze: Directory of Open Access Journals
Externí odkaz: